Reckitt Benckiser Group Plc’s Sell Rating Reaffirmed at Liberum Capital (RB.)
Reckitt Benckiser Group Plc (LON:RB.)‘s stock had its “sell” rating reaffirmed by equities researchers at Liberum Capital in a research report issued on Monday, Analyst Ratings Net reports.
A number of other analysts have also recently weighed in on RB.. Analysts at Canaccord Genuity reiterated a “sell” rating on shares of Reckitt Benckiser Group Plc in a research note to investors on Wednesday, October 2nd. They now have a GBX 4,100 ($65.78) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Reckitt Benckiser Group Plc in a research note to investors on Friday, September 27th. They now have a GBX 4,450 ($71.39) price target on the stock. Finally, analysts at AlphaValue reiterated a “reduce” rating on shares of Reckitt Benckiser Group Plc in a research note to investors on Thursday, September 26th. They now have a GBX 4,332 ($69.50) price target on the stock. Seven equities research analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of GBX 4,612.80 ($74.01).
Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.